Severe Asthma
Also known as: Severe asthma (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00443 | Betamethasone | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. |
| DB12159 | Dupilumab | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. |
| DB00668 | Epinephrine | A hormone and neurotransmitter used to treat allergic reactions, to restore cardiac rhythm, and to control mucosal congestion, glaucoma, and asthma. |
| DB00043 | Omalizumab | A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. |
| DB00860 | Prednisolone | A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers. |
| DB15090 | Tezepelumab | A human monoclonal IgG2λ thymic stromal lymphopoietin (TSLP)-blocking antibody for add-on maintenance therapy in severe asthma. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06612 | Mepolizumab | 1 | Completed | 1 |
| DB06602 | Reslizumab | 2 | Completed | 1 |
| DB00641 | Simvastatin | 2 | Withdrawn | 1 |
| DB15090 | Tezepelumab | 3 | Completed | 1 |
| DB12023 | Benralizumab | 4 | Recruiting | 1 |
| DB12023 | Benralizumab | 4 | Withdrawn | 1 |
| DB01175 | Escitalopram | 4 | Completed | 1 |
| DB06612 | Mepolizumab | 4 | Recruiting | 1 |
| DB00043 | Omalizumab | 4 | Recruiting | 1 |
| DB12023 | Benralizumab | Not Available | Completed | 1 |
| DB12159 | Dupilumab | Not Available | Completed | 2 |
| DB06612 | Mepolizumab | Not Available | Active Not Recruiting | 1 |
| DB06612 | Mepolizumab | Not Available | Completed | 1 |
| DB06612 | Mepolizumab | Not Available | Recruiting | 2 |